Location San Diego, California, United States Regions Greater San Diego Area, West Coast, Western US Gender Female
LinkedIn View on LinkedIn
Before joining Aires, Dr. Masamune was Vice President, Product Development at Palkion Inc., a company focused on the discovery and development of oral drugs to treat anemia. At Palkion she was responsible for all aspects of preclinical development and served as the company’s alliance manager. From 2005 to 2008, Dr. Masamune was Senior Director,
Pharmaceutical Sciences at Neurogen Corp., where she oversaw two Phase 2 candidates for the treatment of insomnia and Parkinson’s disease/restless leg syndrome, one Phase 1 candidate for the treatment of obesity, and a range of early development and late discovery candidates. Previously she spent 15 years in drug development at Pfizer.
She earned a B.S. in organic chemistry from the University of Wisconsin, and a Ph.D. in organic chemistry from the University of California, Los Angeles.
Dr. Masamune completed her post-doctoral fellowship in organic chemistry at M.I.T. under Professor K. Barry Sharpless, contributing to the work for which he was awarded the 2001 Nobel Prize in Chemistry.
